In This Article:
It is not uncommon to see companies perform well in the years after insiders buy shares. The flip side of that is that there are more than a few examples of insiders dumping stock prior to a period of weak performance. So before you buy or sell Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM), you may well want to know whether insiders have been buying or selling.
What Is Insider Buying?
It is perfectly legal for company insiders, including board members, to buy and sell stock in a company. However, such insiders must disclose their trading activities, and not trade on inside information.
We would never suggest that investors should base their decisions solely on what the directors of a company have been doing. But it is perfectly logical to keep tabs on what insiders are doing. As Peter Lynch said, 'insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise'.
View our latest analysis for Mirum Pharmaceuticals
The Last 12 Months Of Insider Transactions At Mirum Pharmaceuticals
Over the last year, we can see that the biggest insider purchase was by President Christopher Peetz for US$93k worth of shares, at about US$18.76 per share. So it's clear an insider wanted to buy, at around the current price, which is US$19.86. Of course they may have changed their mind. But this suggests they are optimistic. If someone buys shares at well below current prices, it's a good sign on balance, but keep in mind they may no longer see value. In this case we're pleased to report that the insider purchases were made at close to current prices.
In the last twelve months Mirum Pharmaceuticals insiders were buying shares, but not selling. They paid about US$15.80 on average. We don't deny that it is nice to see insiders buying stock in the company. However, we do note that they were buying at significantly lower prices than today's share price. You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below. If you want to know exactly who sold, for how much, and when, simply click on the graph below!
Mirum Pharmaceuticals is not the only stock insiders are buying. So take a peek at this free list of growing companies with insider buying.
Insiders at Mirum Pharmaceuticals Have Bought Stock Recently
Over the last quarter, Mirum Pharmaceuticals insiders have spent a meaningful amount on shares. In total, insiders bought US$140k worth of shares in that time, and we didn't record any sales whatsoever. This makes one think the business has some good points.